期刊文献+

扩张型心肌病与缺血性心肌病致心力衰竭患者门控心肌灌注显像对比分析 被引量:7

Gated myocardial perfusion imaging in the treatment of dilated cardiomyopathy and ischemic cardiomyopathy induced heart failure
原文传递
导出
摘要 目的比较扩张型心肌病与缺血性心肌病致心力衰竭患者门控心肌灌注显像特点,为临床合理治疗提供依据。方法扩张型心肌病致心力衰竭患者23例(扩张型心肌病组),缺血性心肌病致心力衰竭患者28例(缺血性心肌病组),均行门控心肌灌注显像,比较2组缺血面积、缺血严重程度、负荷和静息舒张末期容积、负荷和静息收缩末期容积、左室射血分数(left ventricular ejecyion fraction,LVEF)值。结果门控心肌灌注显像提示扩张型心肌病组轻度缺血5例,中度缺血12例,严重缺血6例;缺血性心肌病组轻度缺血2例,中度缺血10例,严重缺血16例。扩张型心肌病组缺血面积[(22.13±9.10)%]大于缺血性心肌病组[(15.25±9.80)%],而局部缺血的严重程度(-2.7±1.2)、LVEF[(33.3±8.5)%]小于缺血性心肌病组[-3.1±1.8、(41.3±6.5)%],2组比较差异有统计学意义(P<0.05);扩张型心肌病组负荷舒张末期容积[(59.97±19.68)mL]、静息舒张末期容积[(55.95±24.36)mL]、负荷收缩末期容积[(38.29±16.90)mL]、静息收缩末期容积[(36.68±17.74)mL]高于缺血性心肌病组[(51.08±17.56)、(49.90±20.31)、(25.95±14.67)、(25.35±15.84)mL],2组比较差异均有统计学意义(P<0.05)。结论扩张型心肌病与缺血性心肌病致心力衰竭具有不同的心肌灌注显像特点,其可用于指导临床治疗。 Objective To study the different characteristics of gated myocardial perfusion imaging of dilated cardiomyopathy and ischemic cardiomyopathy induced heart failure to provide important evidence for clinical therapy. Methods Gated myocardial perfusion imaging was performed in 23 patients with dilated cardiomyopathy (dilated group) and 28 patients with ischemic cardiomyopathy induced heart failure (ischemic group). The ischemic area, severity, loading and resting end-diastolic volume, loading and resting end-systolic volume, and left ventricular ejection fraction (LVEF) were detected and compared between two groups. Results Gated myocardial perfusion imaging showed mild ischemia in 5 patients, moderate ischemia in 12 and severe ischemia in 6 in dilated group, and 2, 10 and 16 patients respectively in ischernic group. The ischemic area was significantly larger in dilated group ((22.13 ±9.1)%) than that in ischemic group ((15.25±9.8)%) (P〈0.05). The severity of local ischemia (-2.7±1.2) and LVEF ((33.3±8.5) %) were lower in dilated group than those in ischemic group (- 3. 1 ± 1. 8, (41. 3±6. 5)%) (P〈0.05). Loading enddiastolic volume ( (59.97± 19.68) mL), resting end-diastolic volume ( (55.95± 24.36) mL), loading end-systolic volume ((38. 29±16.90) mL), resting end-systolic volume ((36.68±17.74) mL) were higher in dilated group than those in ischemic group ((51. 08±17.56), (49. 90±20.31), (25.95±14.67), (25.35±15.84) mL) (P〈0.05). Conclusion Gated myocardial perfusion imaging has different characteristics in patients with dilated cardiomyopathy and ischemic cardiomyopathy induced heart failure, and can be used to guide the therapy.
作者 高玲 贾鹏
出处 《中华实用诊断与治疗杂志》 2015年第9期877-879,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 南京大学医学院附属鼓楼医院青年科研启动基金(QJ2012013)
关键词 扩张型心肌病 门控心肌灌注显像 缺血性心肌病 左心力衰竭 Dilated cardiomyopathy gated myocardial perfusion imaging ischemic cardiomyopathy left cardiac failure
  • 相关文献

参考文献7

  • 1Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation /American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2013,62(16): 147-239.
  • 2Elias E, Pozo E, Paruchuri V, et al. Predictors of cardiac outcomes by CMRI in patients with non ischemic cardiomyopathy[J]. J Am Coll Cardiol, 2013,61 (10) : 612.
  • 3Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemie dilated cardiomyopathy[J]. JAMA, 2013,309 : 896- 908.
  • 4Flotats A, Carri6 I. Radionuclide noninvasive evaluation of heart failure beyond left ventricular function assessment[J]. J Nucl Cardiol,2009,16(2) :304-315.
  • 5Trimble MA, Borges-Neto S, Honeycutt EF, et al. Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with Ieft ventricular dysfunction [ J ]. J Nucl Cardiol, 2008, 15 ( 5 ) : 663- 670.
  • 6贾鹏,高玲.核素心肌灌注显像在冠状动脉心肌桥致无痛性心肌缺血诊断中价值[J].中华实用诊断与治疗杂志,2013,27(12):1175-1176. 被引量:3
  • 7贾鹏,郭万华,杜明华,高玲.门控心肌灌注显像评价肥厚型心肌病心肌缺血的临床价值[J].中华核医学杂志,2010,30(1):28-31. 被引量:4

二级参考文献16

  • 1何作祥.心肌灌注显像的临床应用[J].中华心血管病杂志,2004,32(7):665-667. 被引量:27
  • 2袁晋青,高润霖,乔占瑞,陈珏,尤士杰,吴元,姚民,杨跃进,秦学文,陈纪林.肥厚型心肌病合并冠心病的临床及冠状动脉造影特点分析[J].中华心血管病杂志,2004,32(10):902-903. 被引量:5
  • 3Sanmarez RC.Risk assessment in hypertrophic cardiomyopathy.Heart,2009,95:421.
  • 4Haghjoo M,Mohammadzadeh S,Taherpow M,et al.ST-segment depression as a risk factor in hypertrophic cardiomyopathy.Europace,2009,11:643-649.
  • 5Zipes DP,Libby P,Bonow RO,et al.Braunivald's heart disease:a textbook of cardiovascular medicine(心脏病学--心血管内科学教科书).陈灏珠.译.7版.北京:人民卫生出版社,2007:1563-1570.
  • 6McKenna WJ,Behr ER.Hypertrophic cardiomyopathy:management,risk stratification,and prevention of sudden death.Heart,2002,87:169-176.
  • 7Cortigiani L,Rigo F,Gherardi S,et al.Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy.Am J Carcliol,2008,102:1718-1723.
  • 8Maron BJ.Hypertrophic cardiomyopathy:a systematic review.J Am Med Assoc,2002,287:1308-1320.
  • 9Doevendans PA.Hypertrophic cardiomyopathy:do we have the algorithm for life and death?Circulation,2000,101:1224-1226.
  • 10Losi MA,Betocchi S,Barbati G,et al.Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy.J Am Soc Echocavdiogr,2009,22:76-81.

共引文献5

同被引文献37

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部